Invention Grant
- Patent Title: Aliphatic acid amide derivative
-
Application No.: US17528743Application Date: 2021-11-17
-
Publication No.: US11339151B2Publication Date: 2022-05-24
- Inventor: Yuki Fujii , Masayuki Sakuma , Yoshinori Aihara , Jeremy Besnard , Andrew Simon Bell
- Applicant: Sumitomo Dainippon Pharma Co., Ltd.
- Applicant Address: JP Osaka
- Assignee: Sumitomo Dainippon Pharma Co., Ltd.
- Current Assignee: Sumitomo Dainippon Pharma Co., Ltd.
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JPJP2019-232927 20191224
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D401/04 ; C07D413/04

Abstract:
The present invention relates to a compound represented by formula (1): the compound having antagonist activity against serotonin 5-HT2A receptors and serotonin 5-HT7 receptors; or a pharmaceutically acceptable salt of the compound. (In the formula, Z is a nitrogen atom and the like; Y is carbonyl and the like; m and n are 1 and the like; R1a through R1d, R2a through R2d, and R4a through R4d are a hydrogen atom and the like; R3 is alkyl and the like; and Q is a specific bicyclic group.)
Public/Granted literature
- US20220073506A1 ALIPHATIC ACID AMIDE DERIVATIVE Public/Granted day:2022-03-10
Information query